Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Regent Pacific Group's Days Sales Outstanding or its related term are showing as below:
FRA:RPG'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.71 Med: 55.23 Max: 118.97
Current: 118.97
During the past 13 years, Regent Pacific Group's highest Days Sales Outstanding was 118.97. The lowest was 17.71. And the median was 55.23.
FRA:RPG's Days Sales Outstanding is ranked worse than 81.52% of 947
companies
in the Drug Manufacturers industry
Industry Median: 71.98
vs FRA:RPG: 118.97
Regent Pacific Group's Days Sales Outstanding
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Regent Pacific Group (FRA:RPG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Regent Pacific Group Days Sales Outstanding Related Terms
Regent Pacific Group Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Regent Pacific Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regent Pacific Group Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Regent Pacific Group's Days Sales Outstanding falls into.
Regent Pacific Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regent Pacific Group (FRA:RPG) has a Days Sales Outstanding of 0.00 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Regent Pacific Group and its competitors. Over the past decade, Regent Pacific Group's Days Sales Outstanding has ranged from 17.71 to 118.97. According to the industry distribution chart, Regent Pacific Group ranks #772 out of 947 companies in the Drug Manufacturers industry, placing it in the top 81.5%.
Is Regent Pacific Group's Days Sales Outstanding too high?
Regent Pacific Group's current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 17.71 to a high of 118.97. Based on the distribution chart, Regent Pacific Group ranks #772 out of 947 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Regent Pacific Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Regent Pacific Group ranks #772 out of 947 companies for Days Sales Outstanding. This places Regent Pacific Group in the lower half of its industry. The industry median Days Sales Outstanding is 71.98. Historically, Regent Pacific Group's own Days Sales Outstanding has ranged from 17.71 to 118.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.98, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Regent Pacific Group and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regent Pacific Group's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Regent Pacific Group (FRA:RPG) has a current Days Sales Outstanding of 0.00. The stock's GF Value™ is €0.06, compared to a current price of €0.08 — trading 40% above its estimated fair value. The current Days Sales Outstanding is 0.00. Regent Pacific Group's overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Regent Pacific Group (FRA:RPG), the current Days Sales Outstanding is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regent Pacific Group (FRA:RPG) Overvalued in 2026?
Based on GuruFocus' analysis, Regent Pacific Group stock appears to be overvalued.
The current stock price of €0.08 is trading 40% above its estimated GF Value™ of €0.06.
Key valuation signals for FRA:RPG:
Days Sales Outstanding: 0.00
GF Value™: €0.06 vs. price of €0.08 (40% above fair value)
No single metric tells the full story. See the FRA:RPG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
14GF Score
Get the complete analysis for FRA:RPG
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RPG has been successfully added to your 
